Free Trial

Burning Rock Biotech (BNR) Competitors

Burning Rock Biotech logo
$2.80 -0.10 (-3.45%)
Closing price 04/17/2025 03:56 PM Eastern
Extended Trading
$2.82 +0.02 (+0.54%)
As of 04/17/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BNR vs. AIRS, EUDA, QIPT, BDSX, BMGL, XGN, CORBF, OPGN, CCM, and ENZ

Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include AirSculpt Technologies (AIRS), EUDA Health (EUDA), Quipt Home Medical (QIPT), Biodesix (BDSX), Basel Medical Group (BMGL), Exagen (XGN), Global Cord Blood (CORBF), OpGen (OPGN), Concord Medical Services (CCM), and Enzo Biochem (ENZ). These companies are all part of the "healthcare" industry.

Burning Rock Biotech vs.

Burning Rock Biotech (NASDAQ:BNR) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, community ranking, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

AirSculpt Technologies received 6 more outperform votes than Burning Rock Biotech when rated by MarketBeat users. Likewise, 35.48% of users gave AirSculpt Technologies an outperform vote while only 31.25% of users gave Burning Rock Biotech an outperform vote.

CompanyUnderperformOutperform
Burning Rock BiotechOutperform Votes
5
31.25%
Underperform Votes
11
68.75%
AirSculpt TechnologiesOutperform Votes
11
35.48%
Underperform Votes
20
64.52%

Burning Rock Biotech has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 1.94, indicating that its stock price is 94% more volatile than the S&P 500.

AirSculpt Technologies has lower revenue, but higher earnings than Burning Rock Biotech. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Burning Rock Biotech$515.82M0.06-$92.07M-$1.88-1.49
AirSculpt Technologies$180.35M0.55-$4.48M-$0.15-11.33

30.0% of Burning Rock Biotech shares are owned by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by company insiders. Comparatively, 78.8% of AirSculpt Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Burning Rock Biotech's average media sentiment score of 0.00 beat AirSculpt Technologies' score of -1.00 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company Overall Sentiment
Burning Rock Biotech Neutral
AirSculpt Technologies Negative

AirSculpt Technologies has a consensus target price of $3.75, indicating a potential upside of 120.59%. Given AirSculpt Technologies' stronger consensus rating and higher possible upside, analysts clearly believe AirSculpt Technologies is more favorable than Burning Rock Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Burning Rock Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
AirSculpt Technologies
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

AirSculpt Technologies has a net margin of -4.13% compared to Burning Rock Biotech's net margin of -83.50%. AirSculpt Technologies' return on equity of 2.22% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Burning Rock Biotech-83.50% -60.68% -42.30%
AirSculpt Technologies -4.13%2.22%0.90%

Summary

AirSculpt Technologies beats Burning Rock Biotech on 13 of the 16 factors compared between the two stocks.

Get Burning Rock Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNR vs. The Competition

MetricBurning Rock BiotechMedical laboratories IndustryBusiness SectorNASDAQ Exchange
Market Cap$28.68M$2.78B$6.97B$7.35B
Dividend YieldN/A31.37%2.69%4.30%
P/E Ratio-0.9314.4629.4217.80
Price / Sales0.06192.58163.7297.74
Price / CashN/A57.5631.6134.64
Price / Book0.274.484.543.98
Net Income-$92.07M-$22.21M$195.94M$247.73M
7 Day Performance-6.98%1.82%0.58%1.81%
1 Month Performance-48.53%-6.62%-8.32%-6.98%
1 Year Performance-65.00%6.40%3.73%1.29%

Burning Rock Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BNR
Burning Rock Biotech
0.5029 of 5 stars
$2.80
-3.4%
N/A-63.3%$28.68M$515.82M-0.931,390
AIRS
AirSculpt Technologies
1.0628 of 5 stars
$1.78
-2.5%
$3.75
+111.3%
-68.6%$103.97M$180.35M-12.68240Gap Down
High Trading Volume
EUDA
EUDA Health
0.4317 of 5 stars
$4.10
+7.3%
N/A+139.1%$100.98M$3.81M0.002Short Interest ↑
News Coverage
Gap Down
QIPT
Quipt Home Medical
2.2031 of 5 stars
$2.15
+4.9%
$6.25
+190.7%
-44.9%$92.65M$244.72M-12.65800Gap Down
BDSX
Biodesix
3.1378 of 5 stars
$0.61
+14.2%
$2.95
+387.6%
-54.6%$88.32M$71.32M-1.55220
BMGL
Basel Medical Group
N/A$4.48
-0.4%
N/AN/A$82.68M$10.05M0.0036Gap Up
XGN
Exagen
4.4558 of 5 stars
$4.60
+8.0%
$7.50
+63.0%
+220.7%$82.33M$55.64M-4.89220Short Interest ↑
News Coverage
Positive News
Gap Down
CORBF
Global Cord Blood
N/A$0.65
-43.5%
N/A-48.0%$79.01M$196.12M0.001,200Gap Down
OPGN
OpGen
N/A$4.04
+3.6%
N/A-30.5%$33.76M$2.67M0.00100Analyst Forecast
Gap Down
CCM
Concord Medical Services
0.3928 of 5 stars
$4.22
+5.0%
N/A-33.7%$18.32M$471.70M0.00970Analyst Forecast
News Coverage
Gap Down
High Trading Volume
ENZ
Enzo Biochem
0.5643 of 5 stars
$0.35
+6.5%
N/A-71.9%$18.08M$29.09M0.00520Analyst Forecast
Gap Down

Related Companies and Tools


This page (NASDAQ:BNR) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners